13F Pro

SEC Form 4 reporting owner

Urist Marshall

Urist Marshall has filed 18 Form 4 transactions reported between December 5, 2025 and August 7, 2026, as EVP, Research & Investments of Royalty Pharma plc.

Name as filed: Urist Marshall

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$10.4M
14 lines
Companies
1
with Form 4 filings
Latest transaction
Aug 7, 2026
transaction date

Roles and reported holdings

  • RPRXRoyalty Pharma plc
    Dec 5, 2025 – Aug 7, 2026

    EVP, Research & Investments

    Held directly0 sh as of Jul 1, 2026 · Form 4
    Held indirectly (latest line)244,412 sh as of Aug 7, 2026 · Form 4

    24 months: $10.4M sold

Transaction history

All 18 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 7, 2026RPRXEVP, Research & InvestmentsGiftCode G · indirect3,000—Form 4
Aug 5, 2026RPRXEVP, Research & InvestmentsGrant or awardCode A · direct8,252—Form 4
Jul 1, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · direct9,099$508K@ $55.88Form 4
Jun 24, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · direct9,098$502K@ $55.18Form 4
May 20, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · direct13,684$722K@ $52.75Form 4
May 14, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · direct13,684$726K@ $53.06Form 4
May 6, 2026RPRXEVP, Research & InvestmentsGrant or awardCode A · direct18,197—Form 4
Feb 11, 2026RPRXEVP, Research & InvestmentsGrant or awardCode A · direct19,970—Form 4
Jan 30, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect20,000$822K@ $41.09Form 4
Jan 23, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect20,000$805K@ $40.26Form 4
Jan 16, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect20,000$790K@ $39.52Form 4
Jan 9, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect20,000$816K@ $40.78Form 4
Jan 2, 2026RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect20,000$770K@ $38.48Form 4
Dec 26, 2025RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect20,000$786K@ $39.32Form 4
Dec 19, 2025RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect20,000$768K@ $38.38Form 4
Dec 16, 2025RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect20,000$766K@ $38.32Form 4
Dec 5, 2025RPRXEVP, Research & InvestmentsOpen-market saleCode S · direct18,242$714K@ $39.15Form 4
Dec 5, 2025RPRXEVP, Research & InvestmentsOpen-market saleCode S · indirect23,334$914K@ $39.15Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.